BCAP31 Peptide | 45-019P

BCAP31 Peptide | 45-019P | Gentaur UK, US & Europe Distribution

Short Description: (CT) BCAP31 / BAP31 Peptide

Species: Human

Location: BCAP31 peptide corresponds to 13 amino acids near the C-terminus region of BCAP31.

Tested Application: Bl

Application: BCAP31 Peptide is used for blocking the activity of BCAP31 antibody (catalog number 45-019). The BCAP31 antibody ships at 0.5 mg/mL and the BCAP31 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: BCAP31 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: BCAP31

Alternate Names: CDM, DDCH, BAP31, 6C6-AG, DXS1357E, B-cell receptor-associated protein 31, 6C6-AG tumor-associated antigen, BCR-associated protein 31

NCBI Gene ID: 10134

User Note: N/A

NCBI Official Name: B-Cell Receptor-Associated Protein 31

Background: N/A

Disclaimer: This product is for research use only.